{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T12:51:28Z","timestamp":1782219088744,"version":"3.54.5"},"reference-count":57,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,19]],"date-time":"2024-08-19T00:00:00Z","timestamp":1724025600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA022221"],"award-info":[{"award-number":["R01DA022221"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaacapopen.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JAACAP Open"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.jaacop.2024.08.002","type":"journal-article","created":{"date-parts":[[2024,9,7]],"date-time":"2024-09-07T08:02:42Z","timestamp":1725696162000},"page":"290-300","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["A Double-Blind, Placebo-Controlled Study of Adjunctive Topiramate in Adolescents With Co-Occurring Bipolar and Cannabis Use Disorders"],"prefix":"10.1016","volume":"2","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7929-2311","authenticated-orcid":false,"given":"Jenni E.","family":"Farrow","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1837-4126","authenticated-orcid":false,"given":"Melissa P.","family":"DelBello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1574-151X","authenticated-orcid":false,"given":"Luis R.","family":"Patino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J.","family":"Blom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5602-0137","authenticated-orcid":false,"given":"Jeffrey A.","family":"Welge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaacop.2024.08.002_bib1","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1001\/jama.1990.03450190043026","article-title":"Comorbidity of mental disorders with alcohol and other drug abuse: results from the Epidemiologic Catchment Area ECA Study","volume":"264","author":"Regier","year":"1990","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.jaacop.2024.08.002_bib2","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.drugalcdep.2007.12.016","article-title":"Further evidence of an association between adolescent bipolar disorder with smoking and substance use disorders: a controlled study","volume":"95","author":"Wilens","year":"2008","journal-title":"Drug Alcohol Depend"},{"issue":"7","key":"10.1016\/j.jaacop.2024.08.002_bib3","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.jaac.2014.04.018","article-title":"Risk and protective factors associated with substance use disorders in adolescents with first-episode mania","volume":"53","author":"Stephens","year":"2014","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"issue":"2","key":"10.1016\/j.jaacop.2024.08.002_bib4","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1034\/j.1399-5618.2000.20308.x","article-title":"Impact of substance abuse on the course and treatment of bipolar disorder","author":"Salloum","year":"2000","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.jaacop.2024.08.002_bib5","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.psychres.2017.02.067","article-title":"Substance abuse in patients with bipolar disorder: a systematic review and meta-analysis","volume":"253","author":"Messer","year":"2017","journal-title":"Psychiatry Res"},{"issue":"4","key":"10.1016\/j.jaacop.2024.08.002_bib6","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1399-5618.2008.00584.x","article-title":"Substance use disorders among adolescents with bipolar spectrum disorders","author":"Goldstein","year":"2008","journal-title":"Bipolar Disord"},{"issue":"4","key":"10.1016\/j.jaacop.2024.08.002_bib7","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1176\/ajp.2007.164.4.582","article-title":"Twelve-month outcome of adolescents with bipolar disorder following first hospitalization for a manic or mixed episode","volume":"164","author":"DelBello","year":"2007","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jaacop.2024.08.002_bib8","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.neubiorev.2019.05.017","article-title":"Cannabis use disorder and suicide attempts in bipolar disorder: a meta-analysis","volume":"103","author":"Bartoli","year":"2019","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.jaacop.2024.08.002_bib9","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/00004583-199802000-00009","article-title":"Double-blind and placebo-controlled study of lithium for adolescent bipolar disorders with secondary substance dependency","volume":"37","author":"Geller","year":"1998","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"issue":"1","key":"10.1016\/j.jaacop.2024.08.002_bib10","doi-asserted-by":"crossref","first-page":"113","DOI":"10.4088\/JCP.07m04022","article-title":"A\u00a06-month, double-blind, maintenance trial of lithium monotherapy versus the combination of lithium and divalproex for rapid-cycling bipolar disorder and co-occurring substance abuse or dependence","volume":"70","author":"Kemp","year":"2009","journal-title":"J\u00a0Clin Psychiatry"},{"key":"10.1016\/j.jaacop.2024.08.002_bib11","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/01.pra.0000450325.21791.7e","article-title":"Treatment development and feasibility study of family-focused treatment for adolescents with bipolar disorder and comorbid substance use disorders","volume":"20","author":"Goldstein","year":"2014","journal-title":"J\u00a0Psychiatr Pract"},{"issue":"5","key":"10.1016\/j.jaacop.2024.08.002_bib12","doi-asserted-by":"crossref","first-page":"634","DOI":"10.4088\/JCP.08r04062gry","article-title":"Topiramate in the treatment of substance-related disorders: a critical review of the literature","volume":"71","author":"Shinn","year":"2010","journal-title":"J\u00a0Clin Psychiatry"},{"issue":"6","key":"10.1016\/j.jaacop.2024.08.002_bib13","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1097\/01.chi.0000159151.75345.20","article-title":"A\u00a0pilot controlled trial of topiramate for mania in children and adolescents with bipolar disorder","volume":"44","author":"Delbello","year":"2005","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"issue":"3","key":"10.1016\/j.jaacop.2024.08.002_bib14","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1111\/adb.12350","article-title":"Topiramate and motivational enhancement therapy for cannabis use among youth: a randomized placebo-controlled pilot study","volume":"22","author":"Miranda","year":"2017","journal-title":"Addict Biol"},{"key":"10.1016\/j.jaacop.2024.08.002_bib15","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1097\/00004583-200104000-00014","article-title":"Reliability of the Washington University in St Louis Kiddie Schedule for Affective Disorders and Schizophrenia (WASH-U-KSADS) mania and rapid cycling section","volume":"40","author":"Geller","year":"2001","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"issue":"2","key":"10.1016\/j.jaacop.2024.08.002_bib16","doi-asserted-by":"crossref","first-page":"149","DOI":"10.15288\/jsa.1994.55.149","article-title":"A\u00a0new, semi-structured psychiatric interview for use in genetic linkage studies: a report on the reliability of the SSAGA","volume":"55","author":"Bucholz","year":"1994","journal-title":"J\u00a0Stud Alcohol"},{"issue":"1","key":"10.1016\/j.jaacop.2024.08.002_bib17","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1177\/1073191102009001003","article-title":"Validity of the Wechsler Abbreviated Scale of Intelligence and other very short forms of estimating intellectual functioning","volume":"9","author":"Axelrod","year":"2002","journal-title":"Assessment"},{"key":"10.1016\/j.jaacop.2024.08.002_bib18","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1192\/bjp.133.5.429","article-title":"A\u00a0rating scale for mania: reliability, validity and sensitivity","volume":"133","author":"Young","year":"1978","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.jaacop.2024.08.002_bib19","first-page":"200","article-title":"Use of the Children\u2019s Depression Rating Scale in an inpatient psychiatric population","volume":"44","author":"Poznanski","year":"1983","journal-title":"J\u00a0Clin Psychiatry"},{"key":"10.1016\/j.jaacop.2024.08.002_bib20","series-title":"Clinical Evaluation of Psychotropic Drugs: Principles and Guidelines","first-page":"501","article-title":"Clinical Trials in Children and Adolescents","author":"Klein","year":"1994"},{"issue":"1","key":"10.1016\/j.jaacop.2024.08.002_bib21","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1037\/a0030992","article-title":"Reliability of the Timeline Followback for cocaine, cannabis, and cigarette use","volume":"28","author":"Robinson","year":"2014","journal-title":"Psychol Addict Behav"},{"issue":"7","key":"10.1016\/j.jaacop.2024.08.002_bib22","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1046\/j.1360-0443.2001.967102312.x","article-title":"Marijuana Craving Questionnaire: development and initial validation of a self-report instrument","volume":"96","author":"Heishman","year":"2001","journal-title":"Addiction"},{"issue":"1-3","key":"10.1016\/j.jaacop.2024.08.002_bib23","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.drugalcdep.2008.12.010","article-title":"Reliability and validity of a short form of the Marijuana Craving Questionnaire","volume":"102","author":"Heishman","year":"2009","journal-title":"Drug Alcohol Depend"},{"issue":"11","key":"10.1016\/j.jaacop.2024.08.002_bib24","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1007\/s00213-021-05925-5","article-title":"Effects of topiramate on the association between affect, cannabis craving, and cannabis use in the daily life of youth during a randomized clinical trial","volume":"238","author":"Emery","year":"2021","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.jaacop.2024.08.002_bib25","series-title":"Diagnostic and Statistical Manual of Mental Disorders, 5th ed (DSM-5)","year":"2013"},{"key":"10.1016\/j.jaacop.2024.08.002_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2014.12.024","article-title":"Ecological momentary assessment in the investigation of craving and substance use in daily life: a systematic review [Erratum in: Drug Alcohol Depend. 2015;154:305-314]","volume":"148","author":"Serre","year":"2015","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.jaacop.2024.08.002_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.107957","article-title":"Craving is impermanent and it matters: investigating craving and cannabis use among young adults with problematic use interested in reducing use","volume":"210","author":"Enkema","year":"2020","journal-title":"Drug Alcohol Depend"},{"issue":"11","key":"10.1016\/j.jaacop.2024.08.002_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0278162","article-title":"Thalamocortical functional connectivity and cannabis use in men with childhood attention-deficit\/hyperactivity disorder","volume":"17","author":"Lee","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.jaacop.2024.08.002_bib29","doi-asserted-by":"crossref","DOI":"10.12659\/MSM.939749","article-title":"Exploring the link between attention-deficit hyperactivity disorder and cannabis use disorders: a review","volume":"29","author":"Gujska","year":"2023","journal-title":"Med Sci Monit"},{"issue":"3","key":"10.1016\/j.jaacop.2024.08.002_bib30","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s11920-017-0769-7","article-title":"Towards precision addiction treatment: new findings in co-morbid substance use and attention-deficit hyperactivity disorders","volume":"19","author":"Luo","year":"2017","journal-title":"Curr Psychiatry Rep"},{"issue":"3","key":"10.1016\/j.jaacop.2024.08.002_bib31","doi-asserted-by":"crossref","first-page":"241","DOI":"10.31887\/DCNS.2020.22.3\/rspanagel","article-title":"Cannabinoids and the endocannabinoid system in reward processing and addiction: from mechanisms to interventions","volume":"22","author":"Spanagel","year":"2020","journal-title":"Dialogues Clin Neurosci"},{"issue":"4","key":"10.1016\/j.jaacop.2024.08.002_bib32","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1089\/cap.2022.0098","article-title":"A\u00a0double-blind placebo-controlled pilot study of topiramate in manic adolescents treated with olanzapine","volume":"33","author":"DelBello","year":"2023","journal-title":"J\u00a0Child Adolesc Psychopharmacol"},{"issue":"9","key":"10.1016\/j.jaacop.2024.08.002_bib33","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1177\/02698811231187128","article-title":"Association of cannabis use with neurocognition in adolescents with bipolar disorder","author":"Sultan","year":"2023","journal-title":"J\u00a0Psychopharmacol"},{"issue":"6","key":"10.1016\/j.jaacop.2024.08.002_bib34","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1037\/neu0000641","article-title":"Working memory and short-term memory deficits in ADHD: a bifactor modeling approach","volume":"34","author":"Kofler","year":"2020","journal-title":"Neuropsychology"},{"issue":"6","key":"10.1016\/j.jaacop.2024.08.002_bib35","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1089\/cap.2005.15.931","article-title":"Adjunctive topiramate in hospitalized children and adolescents with bipolar disorders","volume":"15","author":"Barzman","year":"2005","journal-title":"J\u00a0Child Adolesc Psychopharmacol"},{"issue":"4","key":"10.1016\/j.jaacop.2024.08.002_bib36","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1089\/104454602762599862","article-title":"Adjunctive topiramate treatment for pediatric bipolar disorder: a retrospective chart review","volume":"12","author":"DelBello","year":"2002","journal-title":"J\u00a0Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.jaacop.2024.08.002_bib37","first-page":"27","article-title":"Metabolic effects of adding topiramate on aripiprazole in bipolar patients aged between 6-18 years; a randomized, double-blind, placebo-controlled trial","volume":"17","author":"Arman","year":"2022","journal-title":"J\u00a0Res Med Sci"},{"issue":"5","key":"10.1016\/j.jaacop.2024.08.002_bib38","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1089\/cap.2009.0042","article-title":"Comparison of open-label, 8-week trials of olanzapine monotherapy and topiramate augmentation of olanzapine for the treatment of pediatric bipolar disorder","volume":"19","author":"Wozniak","year":"2009","journal-title":"J\u00a0Child Adolesc Psychopharmacol"},{"issue":"9370","key":"10.1016\/j.jaacop.2024.08.002_bib39","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/S0140-6736(03)13370-3","article-title":"Oral topiramate for treatment of alcohol dependence: a randomised controlled trial","volume":"361","author":"Johnson","year":"2003","journal-title":"Lancet"},{"issue":"14","key":"10.1016\/j.jaacop.2024.08.002_bib40","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1001\/jama.298.14.1641","article-title":"Topiramate for Alcoholism Advisory Board; Topiramate for Alcoholism Study Group. Topiramate for treating alcohol dependence: a randomized controlled trial","volume":"298","author":"Johnson","year":"2007","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.jaacop.2024.08.002_bib41","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1111\/acer.12496","article-title":"Topiramate treatment of alcohol use disorder in veterans with posttraumatic stress disorder: a randomized controlled pilot trial","volume":"38","author":"Batki","year":"2014","journal-title":"Alcohol Clin Exp Res"},{"issue":"6","key":"10.1016\/j.jaacop.2024.08.002_bib42","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1111\/acer.12411","article-title":"A\u00a0meta-analysis of topiramate\u2019s effects for individuals with alcohol use disorders","volume":"38","author":"Blodgett","year":"2014","journal-title":"Alcohol Clin Exp Res"},{"issue":"2","key":"10.1016\/j.jaacop.2024.08.002_bib43","first-page":"CD008544","article-title":"Anticonvulsants for alcohol dependence","author":"Pani","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"10.1016\/j.jaacop.2024.08.002_bib44","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.phrs.2005.05.012","article-title":"Effect of topiramate augmentation on two patients suffering from schizophrenia or bipolar disorder with comorbid alcohol abuse","volume":"52","author":"Huguelet","year":"2005","journal-title":"Pharmacol Res"},{"issue":"2","key":"10.1016\/j.jaacop.2024.08.002_bib45","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/ajad.12346","article-title":"A\u00a0randomized, placebo-controlled proof-of-concept trial of adjunctive topiramate for alcohol use disorders in bipolar disorder","volume":"25","author":"Sylvia","year":"2016","journal-title":"Am J Addict"},{"key":"10.1016\/j.jaacop.2024.08.002_bib46","doi-asserted-by":"crossref","first-page":"14","DOI":"10.18332\/tpc\/115167","article-title":"Topiramate for smoking cessation: systematic review and meta-analysis","volume":"6","author":"Lotfy","year":"2020","journal-title":"Tob Prev Cessat"},{"issue":"2","key":"10.1016\/j.jaacop.2024.08.002_bib47","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s40263-020-00780-y","article-title":"Use of topiramate in the spectrum of addictive and eating disorders: a systematic review comparing treatment schemes, efficacy, and safety features","volume":"35","author":"Nourredine","year":"2021","journal-title":"CNS Drugs"},{"issue":"2","key":"10.1016\/j.jaacop.2024.08.002_bib48","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/JCP.0b013e31819c57d4","article-title":"Effects of topiramate on smoking in patients with schizoaffective disorder, bipolar type: response to Khazaal and Zullino","volume":"29","author":"Weinberger","year":"2009","journal-title":"J\u00a0Clin Psychopharmacol"},{"issue":"1","key":"10.1016\/j.jaacop.2024.08.002_bib49","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.schres.2005.10.001","article-title":"A\u00a012-week, randomized, open-label, parallel-group trial of topiramate in limiting weight gain during olanzapine treatment in patients with schizophrenia","volume":"82","author":"Kim","year":"2006","journal-title":"Schizophr Res"},{"issue":"4","key":"10.1016\/j.jaacop.2024.08.002_bib50","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/01.wnf.0000172994.56028.c3","article-title":"Topiramate as an adjuvant treatment with atypical antipsychotics in schizophrenic patients experiencing weight gain","volume":"28","author":"Ko","year":"2005","journal-title":"Clin Neuropharmacol"},{"issue":"3","key":"10.1016\/j.jaacop.2024.08.002_bib51","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/01.jcp.0000162806.46453.38","article-title":"Influence of topiramate on olanzapine-related adiposity in women: a random, double-blind, placebo-controlled study","volume":"25","author":"Nickel","year":"2005","journal-title":"J\u00a0Clin Psychopharmacol"},{"issue":"1","key":"10.1016\/j.jaacop.2024.08.002_bib52","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s12991-020-00319-x","article-title":"Outcomes and safety of concomitant topiramate or metformin for antipsychotics-induced obesity: a randomized-controlled trial","volume":"19","author":"Wang","year":"2020","journal-title":"Ann Gen Psychiatry"},{"issue":"7","key":"10.1016\/j.jaacop.2024.08.002_bib53","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1038\/npp.2010.21","article-title":"Effectiveness of medications used to attenuate antipsychotic-related weight gain and metabolic abnormalities: a systematic review and meta-analysis","volume":"35","author":"Maayan","year":"2010","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.jaacop.2024.08.002_bib54","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2174\/157340012798994867","article-title":"Systematic review and meta-analysis of pharmacological interventions for weight gain from antipsychotics and mood stabilizers","volume":"8","author":"Fiedorowicz","year":"2012","journal-title":"Curr Psychiatry Rev"},{"issue":"1","key":"10.1016\/j.jaacop.2024.08.002_bib55","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/JCP.0b013e31827cb2b7","article-title":"Effect of topiramate on weight gain in patients receiving atypical antipsychotic agents","volume":"33","author":"Mahmood","year":"2013","journal-title":"J\u00a0Clin Psychopharmacol"},{"issue":"1","key":"10.1016\/j.jaacop.2024.08.002_bib56","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1089\/cap.2006.0024","article-title":"Topiramate in adolescents with juvenile bipolar disorder presenting weight gain due to atypical antipsychotics or mood stabilizers: an open clinical trial","volume":"17","author":"Tramontina","year":"2007","journal-title":"J\u00a0Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.jaacop.2024.08.002_bib57","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jsat.2015.09.006","article-title":"Treatment access barriers and disparities among individuals with co-occurring mental health and substance use disorders: an integrative literature review","volume":"61","author":"Priester","year":"2016","journal-title":"J\u00a0Subst Abuse Treat"}],"container-title":["JAACAP Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949732924000590?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949732924000590?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T12:52:24Z","timestamp":1778935944000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949732924000590"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":57,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S2949732924000590"],"URL":"https:\/\/doi.org\/10.1016\/j.jaacop.2024.08.002","relation":{},"ISSN":["2949-7329"],"issn-type":[{"value":"2949-7329","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Double-Blind, Placebo-Controlled Study of Adjunctive Topiramate in Adolescents With Co-Occurring Bipolar and Cannabis Use Disorders","name":"articletitle","label":"Article Title"},{"value":"JAACAP Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaacop.2024.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc. on behalf of American Academy of Child & Adolescent Psychiatry.","name":"copyright","label":"Copyright"}]}}